SCHEMBL18323596

SCHEMBL18323596

Cc1cnn2c(C)nnc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.50
ALDH1A1 P00352 3/20 0.50
CYP1A2 P05177 2/20 0.50
HPGD P15428 2/20 0.50
HSD17B10 Q99714 2/20 0.50
LMNA P02545 1/20 0.50
NFKB1 P19838 1/20 0.50
BLM P54132 1/20 0.50
PMP22 Q01453 1/20 0.50
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DNMT1 P26358 1/20 0.32
GABRA1 P14867 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32
GABRA2 P47869 2/20 0.32
BRD4 O60885 2/20 0.32
CYP3A4 P08684 1/20 0.30
GABRA5 P31644 1/20 0.30
GABRA3 P34903 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20986016 0.81 KDM4E (0.49) KDM4EALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL1665000 0.75 CYP1A2 (0.44) KDM4EALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL9689111 0.74 KDM4E (0.46) KDM4EHPGDHSD17B10LMNAHTT
SCHEMBL9691180 0.71 HPGD (0.56) KDM4EALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL23102794 0.70 GABRA1 (0.40) KDM4EALDH1A1CYP1A2HPGDNFKB1
SCHEMBL18885734 0.70 KDM4E (0.39) KDM4EALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL9690839 0.69 HPGD (0.41) KDM4EALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL21863674 0.68 KDM4E (0.33) KDM4EALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL9689092 0.67 GABRA1 (0.37) KDM4EALDH1A1CYP1A2HPGDHSD17B10
SCHEMBL23104263 0.67 GABRA1 (0.39) CYP1A2GABRA1GABRG2GABRB3GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021254493-A1 CYCLIC COMPOUND HAVING ANTI-TUMOR ACTIVITY AND USE THEREOF 上海翊石医药科技有限公司 2021-12-23 WO disclosed
US-9522910-B2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon Obshchestvo s ogranichennoy otvetstvennostyou “Fusion Pharma” (RU) 2016-12-20 US disclosed